Trazodone

Critical Warnings & Restrictions (Safety First — UK Patient Protection)

Basic Trazodone Information

• INN (International Nonproprietary Name): Trazodone
• Brand Names Available In United Kingdom: Desyrel (worldwide), Trittico and related Trittico formulations in parts of Europe, and multiple generics supplied by manufacturers such as Angelini, Intas and Mylan; check packaging and SPC for exact strengths and brand labelling.
• ATC Code: N06AX05
• Forms & Dosages: Immediate‑release tablets commonly 50mg and 100mg; extended‑release/prolonged‑release forms seen as 75mg, 100mg and 150mg; oral solution is not typically marketed.
• Manufacturers In United Kingdom: Local manufacture not specified; global suppliers include Angelini Group, Intas Pharma, Mylan and others (some list UK supply chains via Intas).
• Registration Status In United Kingdom: Registered and widely marketed across Europe for major depressive disorder; check local licence status and SPC for brand‑specific details.
• OTC / Rx Classification: Prescription only (POM) across markets.

Who needs to read this first?

Anyone prescribed trazodone or considering it for sleep or mood symptoms should read the safety section first.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Trazodone is a prescription‑only medicine and needs careful use in certain groups.

• Avoid or use extreme caution in recent myocardial infarction, severe hepatic impairment and acute intoxication with alcohol or other CNS depressants.
• Use caution with seizure disorders, uncontrolled bipolar disorder (risk of mania), and angle‑closure glaucoma.
• Older adults are at increased risk of orthostatic hypotension and hyponatraemia; start low and titrate slowly.
• Priapism is a rare but urgent side effect requiring immediate medical attention.
• Monitor sodium levels in older patients because of the risk of hyponatraemia/SIADH.

Monitoring Checklist

• Baseline: full medical history, current medicines, ECG if significant cardiac disease or QT‑prolonging drugs.
• Within 1–2 weeks: check for excessive sedation, dizziness, orthostatic symptoms and any signs of hyponatraemia (confusion, seizures).
• At 4–6 weeks: assess mood, suicidality, blood pressure standing and supine, and consider serum sodium in older adults or those on diuretics.
• Ongoing: review for sexual side‑effects, morning sedation and falls risk at each follow‑up; document and adjust dose where needed.

Interaction With Activities (Driving, Workplace Safety Under UK Law)

Many people worry about safety at work and driving when starting trazodone.

Trazodone commonly causes sedation, dizziness and blurred vision, which can affect driving and safety‑critical tasks.

Do Not Drive / Operate Checklist

• Do not drive if you feel drowsy, dizzy or your reactions are slowed after taking trazodone.
• If starting or changing dose, avoid driving until you know how it affects you.
• Report any persistent sedation or visual disturbance to your prescriber before resuming driving.

Employer Notification Steps

• Inform your employer if you perform safety‑critical duties and experience sedation or dizziness.
• Consider occupational health advice for return‑to‑work decisions where performance or safety is affected.

Q&A — “Can I Drive After Taking It In The UK?”

Q: Can I drive after taking trazodone?

A: No — only if you are certain you are not drowsy or impaired.

UK law requires fitness to drive, and sedation or slowed reactions may make driving illegal and dangerous.

If you are starting trazodone or changing dose, avoid driving until you know the effect.

Report any adverse events via the MHRA Yellow Card scheme and tell your prescriber about driving issues.

Usage Basics

INN, Brand Names Available In The UK

What is the drug called and which brands might you see in pharmacy?

INN

Trazodone

Brand

Desyrel is a widely recognised brand name; Trittico and its extended‑release variants appear in some European markets.

Generics

Multiple generics are supplied by manufacturers such as Angelini, Intas and Mylan and are commonly dispensed in UK pharmacies.

Legal Classification (POM, P, GSL)

How is trazodone classified for supply?

• Trazodone is Prescription Only (POM) across markets and is not a controlled drug.
• Prescriptions may be issued on NHS or private prescription forms and can be supplied through community pharmacy, registered online pharmacies or hospital dispensaries.
• Electronic prescribing and NHS e‑prescriptions are widely used in the UK for authorised supply.

Dosing Guide

Standard Regimens (NHS Practice And Practical Notes)

Patients and prescribers commonly use different regimens depending on the indication.

• For major depressive disorder in adults: typical initiation is 75–150 mg/day in divided doses with upward titration to effect.
• Outpatient maximum is usually 400 mg/day, with some inpatient regimens up to 600 mg/day per SPC guidance.
• For off‑label insomnia: low bedtime doses of 25–100 mg are commonly used.
• Assess clinical response in 2–4 weeks and continue treatment for a minimum of six months after remission for depression.

Titration And Monitoring Checklist

• Start at the lowest effective dose for the indication and patient group.
• Increase in small increments while monitoring sedation, blood pressure and mood.
• Reassess suicidality and overall response within the first month and after dose changes.
• Document dose changes and rationale in the medical record.

Adjustments For Comorbidities

Are dose changes needed for specific patients?

• Children: safety and efficacy not established; use is generally not recommended.
• Elderly: start low (often 50 mg at night for insomnia), titrate slowly and monitor for orthostatic hypotension and hyponatraemia.
• Hepatic or renal impairment: use lower initial doses and watch for accumulation and increased adverse effects.

Q&A — “What If I Miss A Dose?”

Q: What should I do if I miss a dose?

A: Take it as soon as you remember unless it is near the time of the next dose — do not double the dose.

For insomnia dosing, skip the missed bedtime dose and take the next dose as scheduled the following night.

If unsure, contact your GP or pharmacist for advice tailored to your regimen.

Interaction Chart (What To Avoid Or Check)

Food And Drinks

Some common items you might pair with medication can change how you feel on trazodone.

Common Drug Conflicts (MHRA Yellow Card Relevance)

Drug interactions can increase risk of serious adverse reactions.

Urgent Action Checklist

• Stop combined use immediately if signs of serotonin syndrome develop (high temperature, agitation, rigidity, rapid heart rate).
• Seek urgent medical care for suspected overdose or severe interactions.
• Report suspected adverse drug reactions to the MHRA Yellow Card scheme.

User Reports & Trends (UK Patient Experience)

What patients commonly tell pharmacists and each other online.

• Common: improved sleep and reduced sleep‑onset problems when low doses are used at night.
• Common: daytime grogginess and morning sedation, especially with higher or poorly timed doses.
• Common: dry mouth, dizziness and gastrointestinal upset such as nausea.
• Less common: libido and sexual side‑effects; some patients switch antidepressant class when this becomes problematic.
• Rare but alarming: priapism; any prolonged erection requires immediate emergency care.

Use patient reports cautiously and balance anecdotes with professional advice.

Encourage reporting of suspected problems via the MHRA Yellow Card and follow‑up with the GP for any concerns.

Access & Purchase Options (Practical UK Routes)

High‑Street Pharmacies And Chains

Where you can collect trazodone after a valid prescription.

• Boots, LloydsPharmacy, Superdrug and independent community pharmacies dispense trazodone on NHS or private prescription.
• Pharmacists must provide counselling consistent with GPhC standards at supply.
• Bring the prescription, a list of current medicines and any allergy information to collection.

Online Pharmacies And NHS E‑Prescriptions

Options when you prefer ordering online or using electronic prescriptions.

In our online pharmacy, trazodone is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

Mechanism & Pharmacology

Simplified Explanation

How trazodone works in plain clinical terms.

SARI

Serotonin Antagonist And Reuptake Inhibitor — it inhibits serotonin reuptake while antagonising 5‑HT2 receptors, producing antidepressant and sedative effects.

Alpha‑1 Blockade

Contributes to orthostatic hypotension and dizziness, especially when standing.

Antihistaminic Activity

Explains the sedative and sleep‑promoting properties at low doses.

Clinical Terms & Classification

Key pharmacokinetic points that affect prescribing and interactions.

• ATC: N06AX05.
• Metabolism: primarily hepatic via CYP3A4; CYP3A4 inhibitors and inducers can alter plasma levels.
• Clinical consequences: adjust dose for hepatic impairment and monitor for increased sedation or adverse effects when combined with CYP3A4 inhibitors.

Indications & Off‑Label Uses

MHRA‑Approved Uses

What trazodone is licensed for in most markets.

Major depressive disorder is the principal regulatory indication historically approved by EMA and FDA; UK prescribers follow BNF and NICE guidance for treatment hierarchies.

Off‑Label Practices In NHS And Private Care

Common off‑label reasons prescribers choose trazodone.

• Low‑dose nocturnal therapy for insomnia, particularly when comorbid depression or SSRI‑induced insomnia exists.
• Adjunctive use for anxiety‑related sleep disturbance or as an adjunct in pain clinics in selected cases.

Documentation Checklist For Off‑Label Use

• Record the rationale for off‑label prescribing in the clinical notes.
• Discuss risks and expected benefits with the patient and document informed consent.
• Plan monitoring intervals and review outcomes objectively.

Key Clinical Findings (Evidence & Safety Signals)

What the literature and regulatory documents emphasise about efficacy and safety.

Clinicians should consult current NICE guidance, the BNF and the SPC for up‑to‑date trial data and safety notices before prescribing.

Alternatives Matrix

NHS Prescribing Alternatives (Comparison Table)

Pros And Cons Checklist

• Consider prior treatment history when switching: inadequate response, tolerability and side‑effect profile steer the choice.
• Match sedative properties to patient needs: mirtazapine or low‑dose amitriptyline for marked insomnia, trazodone for combined sleep and depressive symptoms.
• Discuss childbearing plans, as some antidepressants have pregnancy considerations; involve specialist perinatal mental health services where appropriate.

Common Questions (Practical UK Patient Qs)

• Will it make me sleepy all day?

  Often initially yes; timing the dose at night and using the lowest effective dose reduces daytime sedation.

• How long before it works for depression?

  Expect initial improvements in 2–4 weeks, with full response taking longer; continue for a minimum six months after remission.

• Is it safe in pregnancy?

  Limited data exist; discuss risks and benefits with your prescriber and seek specialist maternal mental health advice if pregnant or planning pregnancy.

• What to do if sexual side‑effects occur?

  Speak with your GP about alternative treatments or dose adjustments; options include switching class or reviewing adjunct strategies.

For specialist advice, contact NHS Mental Health services or local perinatal mental health clinics where appropriate.

NHS Cost & Access Comparison Table

How price and access vary by supply route and region.

Checklist When Ordering Online

• Verify GPhC registration and UK contact details.
• Check batch number and expiry on delivery.
• Keep documentation of prescription and pharmacy contact for any queries.

Registration & Regulation

MHRA Approval Process (Brief Practical)

How regulatory documents guide safe use.

• Marketing authorisations require regulatory review; consult the SPC and PIL for brand‑specific dosing and contraindications.
• Report adverse drug reactions to the MHRA Yellow Card scheme.
• Regulatory documents to check: SPC, PIL and the BNF entry for trazodone.

NHS Prescribing Framework

Prescribing should follow recognised guidance and be documented.

• Align prescribing with NICE, the BNF and local formularies where available.
• Document indication, informed consent for off‑label use and a monitoring plan in the clinical record.
• Follow local audit and governance processes for repeat prescribing and review intervals.

Storage & Handling (UK Household & Pharmacy Guidance)

UK Household Storage (Cold/Damp Climate Considerations)

How to keep trazodone safe at home.

• Store at room temperature between 15–30°C in the original packaging.
• Avoid bathroom cupboards where humidity fluctuates and can damage tablets.
• Keep out of reach of children and pets and use locked storage if household safety is a concern.

Guidance From NHS And Pharmacists

• Return unused or expired medicines to any community pharmacy for safe disposal; do not flush down the toilet.
• Pharmacies should check batch numbers and ensure secure supply chains when dispensing trazodone.
• Online suppliers must be GPhC registered and provide clear contact details for queries or adverse event reporting.

Guidelines For Proper Use (Pharmacist & Patient Safety Checklist)

UK Pharmacist Counselling Style

Essential counselling points to cover at supply.

• Explain the indication, expected onset and that response for depression may take 2–4 weeks.
• Highlight common side‑effects: sedation, dizziness and dry mouth.
• Warn about rare but serious risks such as priapism and hyponatraemia and the need for urgent care if these occur.
• Discuss interactions with alcohol, MAOIs, SSRIs and CYP3A4 inhibitors and driving safety.
• Provide the PIL and document that counselling was given.

NHS Patient Safety Advice

• Arrange GP follow‑up within 2–4 weeks after initiation or dose change to review mood and side‑effects.
• Monitor mood and suicidal thoughts, especially in younger adults and after dose changes.
• Check blood pressure standing and supine if symptomatic and request serum sodium testing in older patients if clinically indicated.
• Taper gradually when stopping to reduce the risk of withdrawal symptoms.
• Contact list: GP, NHS 111 for urgent non‑emergency advice, 999 for emergency symptoms, and report adverse reactions via the MHRA Yellow Card.

Delivery Across United Kingdom